Physician profile
Erum Ansari
NPI 1881830883
$166.39
in general payments reported to CMS, 2019-2025
7 companies · $48.79 in 2025
The $48.79 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.46 · 2022: $34.68 · 2023: $42.93 · 2024: $20.53 · 2025: $48.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $31.77 | 2021-2022 | |
| Glaxosmithkline, LLC. | $29.99 | 2025 | Bexsero |
| Corium, LLC | $22.37 | 2022 | |
| Pfizer INC. | $21.59 | 2023 | |
| Merck Sharp & Dohme LLC | $21.34 | 2023 | Pneumovax 23, Gardasil 9, M-M-R II |
| Seqirus USA INC | $20.53 | 2024 | Flucelvax |
| Phadia US INC. | $18.80 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erum Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.